The result of one-way ANOVA of GLUT1 expression and clinical stage showed that GLUT1 protein expression was increased significantly (P < 0.001) following malignant progression of HCC (Fig.4c). The gene discussed is SLC2A1; the disease is hepatocellular carcinoma.